Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

Morgan K. Moroi, Mohammed Ruzieh, Nader M. Aboujamous, Mehrdad Ghahramani, Gerald V. Naccarelli, John Mandrola, Andrew J. Foy

Research output: Contribution to journalArticle

Abstract

The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article “Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo”, which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.

Original languageEnglish (US)
Article number104835
JournalData in Brief
Volume28
DOIs
StatePublished - Feb 2020

Fingerprint

Amiodarone
Randomized Controlled Trials
Placebos
Cardiology
Meta-Analysis
Thyroid Gland
Datasets
Lung
Skin
Liver

All Science Journal Classification (ASJC) codes

  • General

Cite this

Moroi, Morgan K. ; Ruzieh, Mohammed ; Aboujamous, Nader M. ; Ghahramani, Mehrdad ; Naccarelli, Gerald V. ; Mandrola, John ; Foy, Andrew J. / Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials. In: Data in Brief. 2020 ; Vol. 28.
@article{4f6b1ff722e24cc0bf0c50fe9f1ff098,
title = "Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials",
abstract = "The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article “Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo”, which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.",
author = "Moroi, {Morgan K.} and Mohammed Ruzieh and Aboujamous, {Nader M.} and Mehrdad Ghahramani and Naccarelli, {Gerald V.} and John Mandrola and Foy, {Andrew J.}",
year = "2020",
month = "2",
doi = "10.1016/j.dib.2019.104835",
language = "English (US)",
volume = "28",
journal = "Data in Brief",
issn = "2352-3409",
publisher = "Elsevier BV",

}

Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials. / Moroi, Morgan K.; Ruzieh, Mohammed; Aboujamous, Nader M.; Ghahramani, Mehrdad; Naccarelli, Gerald V.; Mandrola, John; Foy, Andrew J.

In: Data in Brief, Vol. 28, 104835, 02.2020.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

AU - Moroi, Morgan K.

AU - Ruzieh, Mohammed

AU - Aboujamous, Nader M.

AU - Ghahramani, Mehrdad

AU - Naccarelli, Gerald V.

AU - Mandrola, John

AU - Foy, Andrew J.

PY - 2020/2

Y1 - 2020/2

N2 - The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article “Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo”, which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.

AB - The dataset presented here provides a detailed description of the adverse events of amiodarone versus placebo using data from 43 randomized controlled trials. Two authors (M.M., M.R.) independently extracted the data. The dataset also includes baseline patient characteristics, amiodarone loading and maintenance doses, as well as forest plots describing the relative risk (RR) of developing an adverse event related to the pulmonary, thyroid, hepatic, cardiac, skin, gastrointestinal, neurological, and ocular systems. The Mantel-Haenszel random effects model was used to determine the relative risk of adverse events of amiodarone compared to placebo. This dataset is complementary to our article “Meta-analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo”, which was published in the American Journal of Cardiology [1]. The data can be used to assess certain adverse events and their relation to amiodarone loading and/or maintenance dose.

UR - http://www.scopus.com/inward/record.url?scp=85075565965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075565965&partnerID=8YFLogxK

U2 - 10.1016/j.dib.2019.104835

DO - 10.1016/j.dib.2019.104835

M3 - Article

C2 - 31871983

AN - SCOPUS:85075565965

VL - 28

JO - Data in Brief

JF - Data in Brief

SN - 2352-3409

M1 - 104835

ER -